연구성과로 돌아가기
2023 연구자 정보 (560 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Lim, Sung-Nam (Lim, SN) |
Haeundae Paik Hosp, Busan, South Korea Inje Univ, Coll Med, Haeundae Paik Hosp, Busan, South Korea Inje Univ, Haeundae Paik Hosp, Coll Med, Gimhae, South Korea Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Hematol Oncol,Coll Med, Busan, South Korea |
|
|
[JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) [JCR상위 35.6] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [JCR상위 35.6] Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study [JCR상위 35.6] Clinical characteristics, prognostic factors and treatment outcomes in patients diagnosed with primary plasma cell leukemia [JCR상위 1.7] Clinical outcomes of extramammary Paget's disease in Korea: A multicenter, retrospective study [JCR상위 4.6] Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation |
SCIE | 1.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY;ONCOLOGY ONCOLOGY |
sksohn@knu.ac.kr; | ||
|
Lyu, Chuhl Joo (Lyu, CJ) |
Yonsei Univ, Coll Med, Seoul, South Korea Yonsei Univ, Severance Hosp, Dept Pediat Hematol Oncol, Seoul, South Korea Yonsei Univ, Coll Med, Div Pediat Hematol & Oncol, Dept Pediat, Seoul, South Korea |
|
0000-0001-7124-7818 Lyu, Chuhl Joo |
[JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY [JCR상위 4.6] Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation [JCR상위 28.4] Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data |
SCIE | 4.6 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY;ONCOLOGY ONCOLOGY |
sksohn@knu.ac.kr; choihs1786@snubh.org;kanghj@snu.ac.kr; |
||
|
Min, Chang-Ki (Min, CK) |
Seoul St Marys Hosp, Seoul, South Korea Catholic Univ Korea, Seoul St Marys Hematol Hosp, Dept Hematol, Coll Med, Seoul, South Korea Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hematol, Seoul, South Korea Catholic Univ Korea, Seoul St Marys Hosp, Dept Hematol, Coll Med, 222 Banpo Daero, Seoul 06591, South Korea Catholic Univ Korea, Seoul St Marys Hosp, Catholic Hematol Hosp, Coll Med,Dept Hematol, Seoul, South Korea |
|
|
[JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) [JCR상위 69.6] Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma [JCR상위 35.6] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [JCR상위 35.6] Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: a nationwide cohort study by the Korean multiple myeloma working party (KMM 2202) [JCR상위 28.4] Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study [JCR상위 35.6] Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study [JCR상위 35.6] Clinical characteristics, prognostic factors and treatment outcomes in patients diagnosed with primary plasma cell leukemia [JCR상위 35.6] Carfilzomib, lenalidomide, and dexamethasone combination chemotherapy in the real-world 364 Asian multiple myeloma patients on behalf of the Korean multiple myeloma working party (KMM2201 study) [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY HEMATOLOGY;ONCOLOGY ONCOLOGY |
jhmoon@knu.ac.kr;kihyunkimk@gmail.com; ckmin@catholic.ac.kr;hseom@ncc.re.kr; |
||
|
Mun, Yeung-Chul (Mun, YC) |
Ewha Womans Univ, Seoul, South Korea Ewha Womans Univ, Sch Med, Div Hematol Oncol, Seoul, South Korea Ewha Womans Univ, Sch Med, Seoul, South Korea Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul, South Korea |
|
|
[JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) [JCR상위 33.1] Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) [JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY [JCR상위 35.6] Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: a nationwide cohort study by the Korean multiple myeloma working party (KMM 2202) [JCR상위 4.6] Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation |
SCIE | 4.6 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY HEMATOLOGY;ONCOLOGY |
shglory@hanmail.net;HEMAKIM@yuhs.ac; sksohn@knu.ac.kr; |
||
|
Na, Jihyun (Na, J) |
제1저자 | Kyungpook Natl Univ Hosp, Daegu, South Korea |
|
|
[JCR상위 17.7] ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/ REFRACTORY T-CELL LYMPHOMAS [JCR상위 17.7] EFFECT OF AUTOLOGOUS STEM CELL TRANSPLANTATION ON SUBSEQUENT TREATMENT AFTER FIRST RELAPSE IN PATIENTS WITH MULTIPLE MYELOMA |
SCIE | 17.7 | HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION | ||
|
Oh, Myung Seok (Oh, MS) |
Korea Res Inst Chem Technol, Interface Mat & Chem Engn Res Ctr, Daejeon 34114, South Korea Korea Res Inst Chem Technol KRICT, Interface Mat & Chem Engn Res Ctr, Daejeon 34141, South Korea |
|
|
[JCR상위 17.7] Microfluidic formation of surface nanodroplets using green deep eutectic solvents for liquid-liquid nanoextraction and controlled precipitation [JCR상위 19.3] One-step synthesis of a robust, ultrathin, stretchable antifogging copolymer film |
SCIE | 17.7 |
CHEMISTRY, PHYSICAL MATERIALS SCIENCE, MULTIDISCIPLINARY;PHYSICS, APPLIED |
jb.you@knu.ac.kr; hyomin@postech.ac.kr;sgim@kaist.ac.kr; |
||
|
Park, Hyeon Jin (Park, HJ) |
Natl Canc Ctr, Goyang, South Korea Natl Canc Ctr, Ctr Pediat Canc, Dept Pediat, Goyang, South Korea |
|
|
[JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY [JCR상위 28.4] Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data |
SCIE | 17.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY |
choihs1786@snubh.org;kanghj@snu.ac.kr; | ||
|
Park, Seong-Kyu (Park, SK) |
|
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 | SCIE | 17.7 | HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION | ||||
|
Shin, Ho-Jin (Shin, HJ) |
제1저자 |
Pusan Natl Univ Hosp, Busan, South Korea Pusan Natl Univ Hosp, Med Res Inst, Sch Med, Div Hematol Oncol, Busan, South Korea Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Hematol Oncol, Sch Med, Busan, South Korea Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea |
|
|
[JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) [JCR상위 69.6] Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma [JCR상위 28.4] Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study [JCR상위 1.5] Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) [JCR상위 35.6] Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study [JCR상위 1.5] A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit: Results from 12-Month Core Study [JCR상위 35.6] Carfilzomib, lenalidomide, and dexamethasone combination chemotherapy in the real-world 364 Asian multiple myeloma patients on behalf of the Korean multiple myeloma working party (KMM2201 study) [JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY ONCOLOGY HEMATOLOGY;ONCOLOGY |
jhmoon@knu.ac.kr;kihyunkimk@gmail.com; ckmin@catholic.ac.kr;hseom@ncc.re.kr; |
|
|
Suh, Minwoo (Suh, M) |
제1저자 | 교신저자 | Kyungpook Natl Univ, Dept Phys, Daegu 41566, South Korea |
JKI-1897-2023 Suh, Minwoo |
0000-0001-5654-5112 Suh, Minwoo |
[JCR상위 17.7] D4-branes wrapped on a topological disk [JCR상위 17.7] Brane-jet stabilities from Janus and Sasaki-Einstein |
SCIE | 17.7 | PHYSICS, PARTICLES & FIELDS | minwoosuh1@gmail.com; |
|
Won, Jong-Ho (Won, JH) |
Soonchunhyang Univ, Seoul Hosp, Seoul, South Korea Soonchunhyang Univ, Dept Internal Med, Div Hematol Oncol, Seoul Hosp, Seoul, South Korea Kyungpook Natl Univ Hosp, Daegu, South Korea Soon Chun Hyang Univ Hosp, Coll Med, Seoul, South Korea |
AAM-8322-2021 Won, Jongho |
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) [JCR상위 4.6] Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation [JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY;ONCOLOGY HEMATOLOGY |
sksohn@knu.ac.kr; | ||
|
Won, Seunghyun (Won, S) |
Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea Seoul Natl Univ, Med Res Collaborating Ctr, Bundang Hosp, Seongnam, South Korea |
|
|
[JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY [JCR상위 28.4] Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data |
SCIE | 17.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY |
choihs1786@snubh.org;kanghj@snu.ac.kr; | ||
|
Yea, Ji Woon (Yea, JW) |
Yeungam Univ, Med Ctr, Daegu, South Korea |
|
|
[JCR상위 17.7] ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/ REFRACTORY T-CELL LYMPHOMAS [JCR상위 17.7] EFFECT OF AUTOLOGOUS STEM CELL TRANSPLANTATION ON SUBSEQUENT TREATMENT AFTER FIRST RELAPSE IN PATIENTS WITH MULTIPLE MYELOMA |
SCIE | 17.7 | HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION | |||
|
Yoo, Keon Hee (Yoo, KH) |
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea Sungkyunkwan Univ, Samsung Med Ctr, Dept Pediat, Sch Med, Seoul, South Korea |
|
|
[JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY [JCR상위 4.6] Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation [JCR상위 28.4] Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data |
SCIE | 4.6 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY;ONCOLOGY ONCOLOGY |
sksohn@knu.ac.kr; choihs1786@snubh.org;kanghj@snu.ac.kr; |
||
|
Yoon, Sung-Soo (Yoon, SS) |
Seoul Natl Univ, Coll Med, Seoul, South Korea Seoul Natl Univ Hosp, Seoul, South Korea Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea Seoul Natl Univ Hosp, Dept Hematooncol, Seoul, South Korea |
|
|
[JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY [JCR상위 35.6] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [JCR상위 35.6] Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: a nationwide cohort study by the Korean multiple myeloma working party (KMM 2202) [JCR상위 1.5] Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) [JCR상위 1.5] A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit: Results from 12-Month Core Study [JCR상위 4.6] Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation [JCR상위 35.6] Carfilzomib, lenalidomide, and dexamethasone combination chemotherapy in the real-world 364 Asian multiple myeloma patients on behalf of the Korean multiple myeloma working party (KMM2201 study) [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY;ONCOLOGY HEMATOLOGY |
sksohn@knu.ac.kr; |
페이지 이동: